Clinical Trial Update: Mindfulness During COVID-19 [NA]

View source ↗

Summary

A completed clinical trial investigating mindfulness during COVID-19 for migraine disorders and stress-related conditions with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety
• Migraine Disorders
• Stress

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Migraine Disorders, Stress | NA | Status: COMPLETED | Results posted: 2022-03-02